Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have had, or are being considered for, a stem cell transplant using their own cells (called an autologous stem cell transplant), and who are enrolled in a specific named drug program (called the BV HL NDP) where treatment is given according to the approved guidelines for a medicine called Adcetris (brentuximab vedotin)
Who may not be able to join:
- People who are currently taking part in, or are planning to take part in, another clinical trial that involves a treatment or intervention
- People who the doctor running the trial believes are not suitable to participate, for any other reason (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Study Director, Takeda
Phone: +1-877-825-3327
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression Free Survival (PFS) as Assessed by Investigator
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.